Search Results By Year:
Showing 31 - 45 of 193 results
  • Sanfelippo MJ, Engel JM, Onitilo AA. Antithrombin levels are unaffected by warfarin use. Arch Pathol Lab Med.. 2014 Jul;138(7):967-8.
    PubMed ID: 24979180
  • Stankowski RV, Engel JM, Stankowski-Drengler TJ, Liang H, Onitilo AA. PS2-42: All-cause Mortality is Decreased in Women Undergoing Annual Mammography Screening Before Breast Cancer Diagnosis Clinical Medicine & Research. 2014 Sep;12(1-2):ps2-42.
  • Mankarios D, Baade P, Youl P, Mortimer R, Onitilo AA, Russell A, Doi SA. R.. Validation of the QTNM staging system for cancer-specific survival in patients with differentiated thyroid cancer. ENDOCRINE. 2014 Jun;46(2):300-308.
    PubMed ID: 24174176
  • Onitilo AA, Stankowski RV, Berg RL, Engel JM, Glurich IE, Williams G, Doi SA. R.. Type 2 diabetes mellitus, glycemic control, and cancer risk. EUROPEAN JOURNAL OF CANCER PREVENTION. 2014 Mar;23(2):134-40.
    PubMed ID: 23962874
  • Onitilo AA, Stankowski RV, Berg RL, Engel JM, Glurich IE, Williams G, Doi SA. R.. Breast cancer incidence before and after diagnosis of type 2 diabetes mellitus in women: increased risk in the prediabetes phase. EUROPEAN JOURNAL OF CANCER PREVENTION. 2014 Mar;23(2):76-83.
    PubMed ID: 23571511
  • Allen L, Yood M, Wagner E, Aiello Bowles E, Pardee R, Wellman R, Habel L, Nekhlyudov L, Davis R, Onitilo AA, Magid DJ, Pharmacovigilance Research Group. Performance of Claims-based Algorithms for Identifying Heart Failure and Cardiomyopathy Among Patients Diagnosed With Breast Cancer. MEDICAL CARE. 2014 May;52(5):e30-8.
    PubMed ID: 22643199
  • Feigelson HS, zeng C, Pawloski PA, Onitilo AA, Richards CS, Johnson MA, Kauffman TL, Webster J, Nyirends C, Alexander GL, Hwang C, Cross DS, McCarty CA, Davis RL, Schwarzkopf D, Williams AE, Honda S, Daida Y, Kushi LH, Delate T, Goddard K, CERGEN STeam. Does KRAS Testing in Metastatic Colorectal Cancer Impact Overall Survival? A Comparative Effectiveness Study in a Population-Based Sample PLoS One. 2014 May;9(5):e94977.
    PubMed ID: 24788807
  • Wu Y, Liu J, Page D, Peissig P, McCarty C, Onitilo AA, Burnside ES. Comparing the value of mammographic features and genetic variants in breast cancer risk prediction. AMIA Annu Symp Proc. 2014 Nov 14;2014 :1228-37.
    PubMed ID: 25954434
  • Onitilo AA, Engel JM, Salzman-Scott SA, Stankowski RV, Doi SA. A core-item reviewer evaluation (CoRE) system for manuscript peer review. Account Res. 2014;21(2):109-21.
    PubMed ID: 24228975
  • Chi A, Nguyen NP, Welsh JS, Tse W, Monga M, Oduntan O, Almubarak M, Rogers J, Remick SC, Gius D. Strategies of dose escalation in the treatment of locally advanced non-small cell lung cancer: image guidance and beyond. Front Oncol. 2014;4 :156.
    PubMed ID: 24999451
  • Nguyen NP, Jang S, Vock J, Vinh-Hung V, Chi A, Vos P, Pugh J, Vo RA, Ceizyk M, Desai A, Smith-Raymond L, International Geriatric Radiotherapy Group. Feasibility of intensity-modulated and image-guided radiotherapy for locally advanced esophageal cancer. BMC CANCER. 2014 Apr 17;14 :265.
    PubMed ID: 24742268
  • Nguyen ML, Willows B, Khan R, Chi A, Kim L, Nour SG, Sroka T, Kerr C, Godinez J, Mills M, Karlsson U, Altdorfer G, Nguyen NP, Jendrasiak G. The potential role of magnetic resonance spectroscopy in image-guided radiotherapy. Front Oncol. 2014;4 :91.
    PubMed ID: 24847443
  • Chi A, Nguyen NP, Komaki R. The potential role of respiratory motion management and image guidance in the reduction of severe toxicities following stereotactic ablative radiation therapy for patients with centrally located early stage non-small cell lung cancer or lung metastases. Front Oncol. 2014;4 :151.
    PubMed ID: 25009800
  • Chi A, Nguyen NP. 4D PET/CT as a Strategy to Reduce Respiratory Motion Artifacts in FDG-PET/CT. Front Oncol. 2014;4 :205.
    PubMed ID: 25136514
  • Chi A, Nguyen NP. The utility of positron emission tomography in the treatment planning of image-guided radiotherapy for non-small cell lung cancer. Front Oncol. 2014;4 :273.
    PubMed ID: 25340040